Enimmune corporation Statistics
Enimmune corporation (6564) Stock Statistics & Valuation Metrics
Total Valuation
Enimmune corporation has a market cap or net worth of TWD 1.22B. The enterprise value is ―.
- Market Cap
- TWD 1.22B
- Enterprise Value
- ―
Share Statistics
Enimmune corporation has 82,034,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 82,034,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Enimmune corporation’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -57.73%.
- Return on Equity (ROE)
- -1.10
- Return on Assets (ROA)
- -0.36
- Return on Invested Capital (ROIC)
- -57.73%
- Return on Capital Employed (ROCE)
- -1.02
- Revenue Per Employee
- 1.78M
- Profits Per Employee
- -6.09M
- Employee Count
- 27
- Asset Turnover
- 0.11
- Inventory Turnover
- 1.89
Valuation Ratios
The current PE Ratio of Enimmune corporation is -8.87. Enimmune corporation’s PEG ratio is -0.17.
- PE Ratio
- -8.87
- PS Ratio
- 20.20
- PB Ratio
- 10.70
- Price to FCF
- -12.53
- Price to Operating Cash Flow
- -12.87
- PEG Ratio
- -0.17
Income Statement
In the last 12 months, Enimmune corporation had revenue of 48.19M and earned -164.54M in profits. Earnings per share was -2.28.
- Revenue
- 48.19M
- Gross Profit
- 8.02M
- Operating Income
- -185.24M
- Pretax Income
- -164.54M
- Net Income
- -164.54M
- EBITDA
- -176.17M
- Earnings Per Share (EPS)
- -2.28
Cash Flow
In the last 12 months, operating cash flow was -83.44M and capital expenditures -2.75M, giving a free cash flow of -86.19M billion.
- Operating Cash Flow
- -83.44M
- Free Cash Flow
- -86.19M
- Free Cash Flow per Share
- -1.20
Dividends & Yields
Enimmune corporation pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -7.98%
- Earnings Yield
- -11.25%
Stock Price Statistics
- Beta
- 0.47
- 52-Week Price Change
- -27.55%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 44.13
- Average Volume (3m)
- 55.62K
Financial Position
Enimmune corporation as a current ratio of 1.16, with Debt / Equity ratio of 114.37%
- Current Ratio
- 1.16
- Quick Ratio
- 1.08
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- 0.18
- Interest Coverage Ratio
- -46.16
Taxes
In the past 12 months, Enimmune corporation has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Enimmune corporation EV to EBITDA ratio is -9.37, with an EV/FCF ratio of -12.44.
- EV to Sales
- 20.05
- EV to EBITDA
- -9.37
- EV to Free Cash Flow
- -12.44
- EV to Operating Cash Flow
- -12.84
Balance Sheet
Enimmune corporation has TWD 193.45M in cash and marketable securities with TWD 159.57M in debt, giving a net cash position of TWD 33.88M billion.
- Cash & Marketable Securities
- TWD 193.45M
- Total Debt
- TWD 159.57M
- Net Cash
- TWD 33.88M
- Net Cash Per Share
- TWD 0.41
- Tangible Book Value Per Share
- TWD 0.05
Margins
Gross margin is 8.06%, with operating margin of -232.49%, and net profit margin of -226.15%.
- Gross Margin
- 8.06%
- Operating Margin
- -232.49%
- Pretax Margin
- -226.15%
- Net Profit Margin
- -226.15%
- EBITDA Margin
- -213.90%
- EBIT Margin
- -232.49%
